Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Zavrakidis I"'
Autor:
Kok, E.N.D., Havenga, K., Tanis, P.J., Wilt, J.H.W. de, Hagendoorn, J., Peters, E.P., Buijsen, J., Rutten, H.J.T., Kuhlmann, K.E.D., Beets, G.L., Aalbers, A.G.J., Kok, N.F.M., Ruers, T.J.M., Kobus, C.B.H.A., Siemons, S.V., Grootscholten, C., Dewit, L.G.H., Berg, J.G. van den, Zavrakidis, I., Jong, K.P. de, Hospers, G.A.P., Karrenbeld, A., Geijsen, E.D., Punt, C.J.A., Rutten, H., Radema, S., Intven, M.P.W., Roodhart, J.M.L., Holman, F., Kapiteijn, E., Melenhorst, J., Cnossen, J.S., Creemers, G.J.M., Dutch Stage IV Rectal Canc Grp
Publikováno v:
British Journal of Surgery, 107(5), 537-545. Wiley
British Journal of Surgery, 107, 537-545
British Journal of Surgery, 107, 5, pp. 537-545
British Journal of Surgery, 107(5), 537. John Wiley and Sons Ltd
British Journal of Surgery, 107(5), 537-545. WILEY
British journal of surgery, 107(5), 537-545. John Wiley and Sons Ltd
British Journal of Surgery, 107, 537-545
British Journal of Surgery, 107, 5, pp. 537-545
British Journal of Surgery, 107(5), 537. John Wiley and Sons Ltd
British Journal of Surgery, 107(5), 537-545. WILEY
British journal of surgery, 107(5), 537-545. John Wiley and Sons Ltd
The optimal treatment sequence for patients with rectal cancer and synchronous liver metastases remains unclear. The aim of this study was to evaluate the feasibility and effectiveness of short-course pelvic radiotherapy (5 × 5 Gy) followed by syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dda57979bdec1b9e68baa4d9a19de2a
https://doi.org/10.1002/bjs.11418
https://doi.org/10.1002/bjs.11418
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
In 't Veld EH; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Keizer R; Department of Ocular Oncology, The Rotterdam Eye Hospital, Rotterdam, The Netherlands., Post N; Department of Dermatology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Versteeg J; Department of Ocular Oncology, The Rotterdam Eye Hospital, Rotterdam, The Netherlands., Verdijk R; Department of Pathology, Section Ophthalmic Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Naus N; Department of Ophthalmology, Erasmus Medical Centre, Rotterdam, The Netherlands., Relyveld G; Department of Dermatology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Crijns M; Department of Dermatology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Smith M; Sarcoma and Skin Unit, Department of Academic Surgery, Royal Marsden NHS Trust, London, UK., Grünhagen D; Department of Surgical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands., Wakkee M; Department of Dermatology, Erasmus Medical Centre, Rotterdam, The Netherlands., Paridaens D; Department of Ocular Oncology, The Rotterdam Eye Hospital, Rotterdam, The Netherlands.; Department of Ophthalmology, Erasmus Medical Centre, Rotterdam, The Netherlands., Zavrakidis I; Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Mooyaart A; Department of Pathology, Section Ophthalmic Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands., van Akkooi A; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Strauss D; Sarcoma and Skin Unit, Department of Academic Surgery, Royal Marsden NHS Trust, London, UK., Verhoef C; Department of Surgical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands., Wouters M; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Hayes A; Sarcoma and Skin Unit, Department of Academic Surgery, Royal Marsden NHS Trust, London, UK., van Houdt W; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
Journal of surgical oncology [J Surg Oncol] 2022 Mar; Vol. 125 (4), pp. 730-735. Date of Electronic Publication: 2022 Jan 06.
Autor:
van Houdt WJ; Sarcoma Unit, Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., IJzerman NS; Sarcoma Unit, Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Schrijver AM; Sarcoma Unit, Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Huis In 't Veld E; Sarcoma Unit, Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Thway K; Sarcoma Unit, Department of Pathology, Royal Marsden Hospital, London, UK., Jones RL; Sarcoma Unit, Department of Medical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Fotiadis N; Sarcoma Unit, Department of Radiology, Royal Marsden Hospital, London, UK., Hayes AJ; Sarcoma Unit, Department of Surgical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Bruining A; Sarcoma Unit, Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Zavrakidis I; Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Epidemiology and Biostatistics, Amsterdam, the Netherlands., van Coevorden F; Sarcoma Unit, Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Steeghs N; Sarcoma Unit, Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Strauss DC; Sarcoma Unit, Department of Surgical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Smith MJF; Sarcoma Unit, Department of Surgical Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK.
Publikováno v:
Annals of surgery [Ann Surg] 2021 Dec 01; Vol. 274 (6), pp. e1093-e1098.
Autor:
Zavrakidis I; Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, Netherlands., Jóźwiak K; Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, Netherlands.; Brandenburg Medical School Theodor Fontane, Institute of Biostatistics and Registry Research, Neuruppin, Germany., Hauptmann M; Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, Netherlands. michael.hauptmann@mhb-fontane.de.; Brandenburg Medical School Theodor Fontane, Institute of Biostatistics and Registry Research, Neuruppin, Germany. michael.hauptmann@mhb-fontane.de.
Publikováno v:
Scientific reports [Sci Rep] 2020 Jun 04; Vol. 10 (1), pp. 9143. Date of Electronic Publication: 2020 Jun 04.
Autor:
IJzerman NS; Sarcoma Unit, Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: n.ijzerman@nki.nl., Mohammadi M; Leiden University Medical Center, Department of Medical Oncology, Leiden, the Netherlands. Electronic address: m.mohammadi@lumc.nl., Tzanis D; Department of Surgery, Institut Curie, PSL University, Paris, France(2). Electronic address: dimitri.tzanis@curie.fr., Gelderblom H; Leiden University Medical Center, Department of Medical Oncology, Leiden, the Netherlands. Electronic address: a.j.gelderblom@lumc.nl., Fiore M; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Surgery, Milano, Italy. Electronic address: marco.fiore@istitutotumori.mi.it., Fumagalli E; Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Medical Oncology, Milano, Italy. Electronic address: elena.fumagalli@istitutotumori.mi.it., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland. Electronic address: piotr.rutkowski@coi.pl., Bylina E; Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland. Electronic address: elab@coi.waw.pl., Zavrakidis I; Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Epidemiology and Biostatistics, Amsterdam, the Netherlands. Electronic address: izavrakidis@mail.com., Steeghs N; Sarcoma Unit, Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: n.steeghs@nki.nl., Bonenkamp HJ; Radboud University Medical Centre, Department of Surgical Oncology, Nijmegen, the Netherlands. Electronic address: han.bonenkamp@radboudumc.nl., van Etten B; University of Groningen, University Medical Centre Groningen, Department of Surgery, Groningen, the Netherlands. Electronic address: b.van.etten@umcg.nl., Grünhagen DJ; Erasmus MC - Cancer Institute, Department of Surgical Oncology, Rotterdam, the Netherlands. Electronic address: d.grunhagen@erasmusmc.nl., Rasheed S; Sarcoma Unit, Department of Surgical Oncology, Royal Marsden Hospital, London, UK. Electronic address: Shahnawaz.rasheed@rmh.nhs.uk., Tekkis P; Sarcoma Unit, Department of Surgical Oncology, Royal Marsden Hospital, London, UK. Electronic address: paris.tekkis@rmh.nhs.uk., Honoré C; Gustave Roussy, Surgical Oncology department, France(2). Electronic address: charles.honore@gustaveroussy.fr., van Houdt W; Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Surgical Oncology, Amsterdam, the Netherlands. Electronic address: w.v.houdt@nki.nl., van der Hage J; Leiden University Medical Center, Department of Surgery, Leiden, the Netherlands. Electronic address: j.a.van_der_hage@lumc.nl., Bonvalot S; Department of Surgery, Institut Curie, PSL University, Paris, France(2). Electronic address: sylvie.bonvalot@curie.fr., Schrage Y; Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Surgical Oncology, the Netherlands and European School of Soft Tissue Sarcoma Surgery, Amsterdam, the Netherlands. Electronic address: y.schrage@nki.nl., Smith M; Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Surgical Oncology, Amsterdam, the Netherlands. Electronic address: Myles.Smith@rmh.nhs.uk.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2020 Jun; Vol. 46 (6), pp. 1124-1130. Date of Electronic Publication: 2020 Mar 06.
Autor:
Saadani H; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Hiel B; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands b.vd.hiel@nki.nl., Aalbersberg EA; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., Zavrakidis I; Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; and., Hoekstra OS; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Boellaard R; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Stokkel MPM; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2019 Nov; Vol. 60 (11), pp. 1545-1552. Date of Electronic Publication: 2019 Sep 03.
Autor:
Buoninfante OA; Division of Tumor Biology and Immunology, Amsterdam, CX 1066, The Netherlands., Pilzecker B; Division of Tumor Biology and Immunology, Amsterdam, CX 1066, The Netherlands., Aslam MA; Division of Tumor Biology and Immunology, Amsterdam, CX 1066, The Netherlands., Zavrakidis I; Division of Psychosocial Research and Epidemiology, Amsterdam, CX 1066, The Netherlands., van der Wiel R; Division of Tumor Biology and Immunology, Amsterdam, CX 1066, The Netherlands., van de Ven M; Mouse Clinic for Cancer and Aging research (MCCA) Transgenic Facility, The Netherlands Cancer Institute, Amsterdam, CX 1066, The Netherlands., van den Berk PCM; Division of Tumor Biology and Immunology, Amsterdam, CX 1066, The Netherlands., Jacobs H; Division of Tumor Biology and Immunology, Amsterdam, CX 1066, The Netherlands.
Publikováno v:
Oncotarget [Oncotarget] 2018 Apr 10; Vol. 9 (27), pp. 18832-18843. Date of Electronic Publication: 2018 Apr 10 (Print Publication: 2018).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alshuhri, Mohammed S.1 (AUTHOR) a.alhulail@psau.edu.sa, Alduhyyim, Abdulaziz2 (AUTHOR) aduhyyim@moh.gov.sa, Al-Mubarak, Haitham3 (AUTHOR) haitham.al-mubarak@mountsinai.org, Alhulail, Ahmad A.1 (AUTHOR) ag.alqahtani@psau.edu.sa, Alomair, Othman I.4 (AUTHOR) oalomir@ksu.edu.sa, Madkhali, Yahia5 (AUTHOR) ymedkhali@jazanu.edu.sa, Alghuraybi, Rakan A.6 (AUTHOR) ralgharibi@sfhm.med.sa, Alotaibi, Abdullah M.7 (AUTHOR) amalotaibi@kfmc.med.sa, Alqahtani, Abdullalh G. M.1 (AUTHOR)
Publikováno v:
Diagnostics (2075-4418). Dec2023, Vol. 13 Issue 23, p3541. 13p.